Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,551 | 1,128 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,678 | 130 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,290 | 193 | $0 (2024) |
| GlaxoSmithKline, LLC. | $999.58 | 77 | $0 (2024) |
| Amgen Inc. | $846.10 | 59 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $796.11 | 85 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $747.15 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $661.98 | 50 | $0 (2022) |
| Novo Nordisk Inc | $632.64 | 76 | $0 (2024) |
| ABBVIE INC. | $582.72 | 36 | $0 (2024) |
| Lilly USA, LLC | $536.54 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,819 | 111 | GlaxoSmithKline, LLC. ($235.62) |
| 2023 | $608.15 | 32 | AbbVie Inc. ($188.90) |
| 2022 | $774.84 | 43 | Lilly USA, LLC ($135.87) |
| 2021 | $1,573 | 105 | Esperion Therapeutics, Inc. ($211.92) |
| 2020 | $1,369 | 107 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($178.70) |
| 2019 | $2,334 | 232 | Novartis Pharmaceuticals Corporation ($534.26) |
| 2018 | $2,510 | 252 | Novartis Pharmaceuticals Corporation ($359.58) |
| 2017 | $2,562 | 246 | Janssen Pharmaceuticals, Inc ($544.54) |
All Payment Transactions
1,128 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: ANTIBIOTIC | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Obesity | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.90 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $48.05 | General |
| Category: Hematology | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.73 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: Hematology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Immunology | ||||||
| 10/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.84 | General |
| Category: Cardiovascular | ||||||
| 10/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: ANTIBIOTIC | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/20/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Hematology | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 534 | 977 | $153,857 | $62,128 |
| 2022 | 5 | 520 | 1,106 | $150,815 | $63,771 |
| 2021 | 4 | 564 | 1,175 | $148,592 | $68,325 |
| 2020 | 30 | 2,414 | 20,535 | $382,359 | $122,332 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 327 | 747 | $107,951 | $42,094 | 39.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 98 | 98 | $25,714 | $11,782 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 99 | $9,947 | $4,215 | 42.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 19 | 20 | $5,072 | $2,026 | 39.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $5,173 | $2,012 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 371 | 927 | $128,685 | $53,693 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 117 | $10,975 | $5,051 | 46.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 22 | 22 | $5,505 | $2,704 | 49.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 20 | 21 | $5,305 | $2,214 | 41.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 19 | 19 | $345.00 | $108.55 | 31.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 399 | 964 | $128,574 | $58,592 | 45.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 125 | 171 | $15,512 | $7,455 | 48.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 17 | 17 | $4,112 | $2,160 | 52.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 23 | 23 | $394.00 | $117.96 | 29.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 441 | 1,025 | $193,615 | $58,754 | 30.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 21 | 1,440 | $51,840 | $21,534 | 41.5% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2020 | 12 | 15,750 | $47,250 | $13,753 | 29.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 135 | 179 | $23,181 | $6,763 | 29.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 288 | 364 | $11,648 | $3,776 | 32.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 221 | 227 | $11,577 | $3,750 | 32.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 191 | 198 | $8,118 | $2,620 | 32.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 216 | 237 | $5,688 | $1,806 | 31.8% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 117 | 166 | $4,814 | $1,575 | 32.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 11 | 11 | $3,948 | $1,497 | 37.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 308 | 435 | $3,045 | $1,289 | 42.3% |
About Dr. Stephen Smith, MD
Dr. Stephen Smith, MD is a Internal Medicine healthcare provider based in Huntington, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417993486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Smith, MD has received a total of $13,551 in payments from pharmaceutical and medical device companies, with $1,819 received in 2024. These payments were reported across 1,128 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($13,551).
As a Medicare-enrolled provider, Smith has provided services to 4,032 Medicare beneficiaries, totaling 23,793 services with total Medicare billing of $316,558. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Huntington, WV
- Active Since 06/20/2006
- Last Updated 04/23/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1417993486
Products in Payments
- ENTRESTO (Drug) $1,418
- XARELTO (Drug) $901.62
- ELIQUIS (Drug) $744.53
- TRELEGY ELLIPTA (Drug) $622.25
- JARDIANCE (Drug) $522.81
- NUEDEXTA (Drug) $502.54
- XIFAXAN (Drug) $484.68
- VRAYLAR (Drug) $419.55
- Ozempic (Drug) $390.22
- Vascepa (Drug) $352.88
- Aimovig (Biological) $341.73
- INVOKANA (Drug) $283.81
- NEXLETOL (Drug) $273.26
- LEQVIO (Drug) $260.75
- MOUNJARO (Drug) $240.99
- NURTEC ODT (Drug) $236.85
- LINZESS (Drug) $233.86
- FARXIGA (Drug) $232.17
- EVENITY (Biological) $195.79
- ACCRUFER (Drug) $191.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntington
Aamir Cheema, M.d, M.D
Internal Medicine — Payments: $207,509
Kofi Osei, Md, MD
Internal Medicine — Payments: $78,202
Wesam Frandah, Md, MD
Internal Medicine — Payments: $28,363
Murad Kheetan, Md, MD
Internal Medicine — Payments: $25,358
Rameez Sayyed, Md, MD
Internal Medicine — Payments: $24,444
David Patick, Md, MD
Internal Medicine — Payments: $23,768